REGISTRATION AND CHECK-IN

Click here to register

April 11, 2026 | 7:30AM - 5:00PM CDT
Baylor St. Luke's Medical Center McNair Campus
7200 Cambridge, Houston, Texas 77030

Available by in-person 

Needs Statement

Neuromuscular medicine, a specialized branch of neurology, has experienced significant advancements over the past year, introducing new diagnostic and therapeutic approaches that directly impact both outpatient and inpatient neurological care. Since the last seminar, emerging evidence and innovations have reshaped clinical practice in areas such as inflammatory diabetic neuropathies, novel pharmacologic pipelines for amyotrophic lateral sclerosis (ALS), and updated treatment strategies for amyloidosis. Additionally, evolving knowledge in the diagnosis and management of sensory neuronopathies, small fiber neuropathy, and neuromuscular complications of systemic conditions like Sjögren’s syndrome necessitates ongoing education for clinicians. The introduction of new therapies for myasthenia gravis and the refined role of muscle biopsy in clinical decision-making further underscore the need for practitioners to stay current. To address these gaps, this conference will convene leading experts from prestigious institutions to provide evidence-based updates and practical guidance on these rapidly developing topics, ensuring neurologists and related specialists are equipped to deliver optimal patient care.

Target Audience

Designed for individuals interested in learning about new advances in the diagnosis and treatment of neuromuscular disorders, who are primarily neurologists, physiatrists, physician assistants, nurses, neurology fellows, residents, and students. 

Learning Objectives

At the conclusion of the conference, participants should be able to:

•  Identify diabetic inflammatory neuropathies and differentiate them from the rest of diabetic neuropathies.
• ·Select proper patients for muscle and nerve biopsies
• Implement new therapeutic paradigm for myasthenia gravis
• Apply new protocol for diagnosis and treatment of amyloid neuropathy

Educational Methods

Lecture

Activity Evaluation

Evaluation by questionnaire will address program content, presentation, and possible bias.

ADDITIONAL INFORMATION

For any conference questions, contact Linda Carter [email protected].